Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
12.68
-0.32 (-2.46%)
Feb 21, 2025, 4:00 PM EST - Market closed
Rapport Therapeutics Market Cap
Rapport Therapeutics has a market cap or net worth of $463.79 million as of February 21, 2025.
Market Cap
463.79M
Enterprise Value
144.78M
1-Year Change
n/a
Ranking
Category
Stock Price
12.68
Market Cap Chart
Since the IPO on June 7, 2024, Rapport Therapeutics's market cap has decreased from $601.40M to $463.79M, a decrease of -22.88%. That is a compound annual growth rate of -30.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2025 | 475.49M | -26.72% |
| Dec 31, 2024 | 648.87M | 7.89% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |